Cargando…
Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts
BACKGROUND: Bone is one of the most frequent metastatic sites of advanced breast cancer. Current therapeutic agents aim to inhibit osteoclast-mediated bone resorption but only have palliative effects. During normal bone remodeling, the balance between bone resorption and osteoblast-mediated bone for...
Autores principales: | Liu, Xuxiang, Cao, Minghui, Palomares, Melanie, Wu, Xiwei, Li, Arthur, Yan, Wei, Fong, Miranda Y., Chan, Wing-Chung, Wang, Shizhen Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198446/ https://www.ncbi.nlm.nih.gov/pubmed/30348200 http://dx.doi.org/10.1186/s13058-018-1059-y |
Ejemplares similares
-
Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis
por: Fong, Miranda Y., et al.
Publicado: (2015) -
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
por: Yan, Wei, et al.
Publicado: (2018) -
MiR-218-5p-dependent SOCS3 downregulation increases osteoblast differentiation inpostmenopausal osteoporosis
por: Zhou, Qian, et al.
Publicado: (2023) -
Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation
por: Zunich, Samantha M, et al.
Publicado: (2012) -
Cancer-cell-secreted Extracellular Vesicles Suppress Insulin Secretion through miR-122 to Impair Systemic Glucose Homeostasis and Contribute to Tumour Growth
por: Cao, Minghui, et al.
Publicado: (2022)